Steven Cohen’s Xenon Pharmaceuticals XENE Stock Holding History

Steven Cohen’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,300	Closed	-$541K	–	4648
2026 Q1	$541K	Hold	9,300	–	–	﹤0.01%	3084
2025 Q4	$417K	Buy	+9,300	New	+$391K	﹤0.01%	3327

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Steven Cohen's XENE Position: Q2 2026 in Review

Steven Cohen opened a new position in Xenon Pharmaceuticals (XENE) in Q2 2026: 130,378 shares worth $7.87M. The stake represents 0.01% of the portfolio and ranks #1438 among its holdings. This is a return to the name: Steven Cohen previously reported a position in XENE as recently as Q1 2025.

Steven Cohen first reported a position in XENE in Q1 2015 and has held it in 41 quarters since. The position peaked at $93.5M in Q4 2021. 314 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Steven Cohen held 130,378 shares of Xenon Pharmaceuticals worth $7.87M as of Q2 2026.
Xenon Pharmaceuticals was a new Steven Cohen position in Q2 2026.
Xenon Pharmaceuticals made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1438 holding.
Steven Cohen first reported a position in Xenon Pharmaceuticals in Q1 2015 and has held it in 41 quarters since.
Steven Cohen's Xenon Pharmaceuticals position peaked at $93.5M in Q4 2021.
314 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.